Healthcare IT News October 21, 2024
The Agency says AI can transform multiple aspects of healthcare, but it is difficult to fully oversee and regulate the technology without the assistance of all sectors involved.
The Food and Drug Administration (FDA) has released its perspective on regulating AI in healthcare and biomedicine, stating that oversight needs to be coordinated across all regulated industries, international organizations and the U.S. government.
The Agency says it regulates industries that distribute their products to the global market, and therefore U.S. regulatory standards must be compatible with international standards.
It highlighted that it is working to accomplish this by coleading an AI working group of the International Medical Device Regulators Forum that both promotes AI best practices globally and leads...
Today's Sponsors
Today's Sponsor